Personalized medicine has the potential to
change the way we think about, identify and manage health problems. It is
already having an exciting impact on both clinical research and patient care,
and this impact will grow as our understanding and technologies improve.
It is already clear that
personalized medicine promises three key benefits:
- Better diagnoses and earlier
interventions. Molecular analysis could determine precisely which variant of
a disease a person has, or whether they are susceptible to drug toxicities,
to help guide treatment choices. For preventive medicine, such analysis could
improve the ability to identify which individuals are predisposed to develop
a particular condition — and guide decisions about interventions that might
prevent it, delay its onset or reduce its impact.
- More efficient drug development. A better
understanding of genetic variations could help scientists identify new
disease subgroups and their associated molecular pathways, and design drugs
that target them. Molecular analysis could also help select patients for
inclusion in, or exclusion from, late stage clinical trials — helping gain
approval for drugs that might otherwise be abandoned because they appear to
be ineffective in the larger patient population.
- More effective therapies. Currently,
physicians often have to use trial and error to find the most effective
medication for each patient. As we learn more about which molecular
variations best predict how a patient will react to a treatment, and develop
accurate and cost-effective tests, doctors will have more information to
guide their decision about which medications are likely to work best. Testing
is already being used to find the one in four women likely to respond to a
particular breast cancer drug. In addition, testing could help predict the
best dosing schedule or combination of drugs for a particular patient.
Read about the challenges
presented by personalized medicine.
Go back to Personalized Medicine 101 main page.